Our Latest Articles
AI in Healthcare
June 30, 2026
How Sanofi’s Blood-Brain Barrier Shuttle is Rewriting the Script for Rare Diseases
Second Quarter 2026 Results
Second quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation will be followed by a Q&A session.
The Power of Chasing A Dream
Every day, we chase the miracles of science to improve people’s lives. We apply our deep understanding of the immune system to develop breakthrough innovations in medicines and vaccines so you can focus on what matters most, chasing your dreams. If you’re chasing your dreams, remember... you’re not alone. We’re right beside you
People Stories
We’re proud to spotlight those who inspire us to keep going further in the work we do.
Céline, living with secondary progressive multiple sclerosis
France
We are an R&D driven, AI-powered biopharmaceutical company committed to improving people’s lives and delivering compelling growth.
About Us
Who We Are
We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.
Our Pipeline
5
Therapeutic areas
77
Compounds in clinical development
21
Clinical trials in phase 3
Pursue Progress. Discover Extraordinary.
Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.